Embedded in nature: human health and biodiversity. by Chivian, Eric & Bernstein, Aaron S
A loss of global biodiversity, namely a reduction in the variety of life
on Earth, is rarely given much attention by physicians or environ-
mental scientists. Like most people, they do not spend much time
thinking about their relationship to other life forms, and they gener-
ally act, unknowingly, as if human beings were separate from the rest
of nature—as if we could change the composition of the atmosphere
and degrade the land and the oceans without these alterations having
much effect on us. It is this disconnect that is at the core of the global
environmental crisis—that policy makers and the public by and large
do not understand that their health and lives are ultimately depen-
dent on other species and on the integrity of the planet’s ecosystems,
and, as a result, they do not appreciate the urgent need to protect the
natural world.
Approximately 1.7 million species have been identified on Earth
and given Linnaean names (United Nations Environment Programme
1996), but there may be 10 times that number in all, and perhaps
many times more if we include microbial diversity (Pimm et al.
1995). Species interact with each other and with their physical and
chemical environments to make up ecosystems such as forests and
wetlands. Stratospheric ozone depletion, pollution, the introduction
of alien species, the overharvesting of species, and increasingly global
climate change (Walther et al. 2002) all threaten biodiversity and thus
ecosystem function. However, the degradation, reduction, and frag-
mentation of habitats on land, in fresh water, and in the oceans are
the greatest threats (Pimm and Raven 2000). All of these factors are
the result of human activity and are driven by unsustainable con-
sumption, especially in the industrialized world, and rising human
populations. Together they have disrupted grassland, river, lake, coral
reef, and other ecosystems at alarming levels, and have raised the rate
of species extinctions to 100 and, by some estimates, even to 1,000
times natural background rates (Pimm et al.1995). 
The loss of species deprives us of invaluable tools for biomedical
research that provide insights into how human cells and organ sys-
tems function in health and illness, and precludes our developing
important new medicines for currently untreatable human diseases.
Cone snails, a large genus of some 500 species that live mostly in
tropical coral reefs and mangroves, are a case in point. These remark-
able creatures capture their prey by lancing them with a harpoon
coated with a cocktail of toxic peptides, which bind to an enormous
variety of ion channels and receptors on cellular membranes through-
out the animal kingdom (Olivera et al. 1990). Each species may make
as many as 100 distinct toxins, so there may be as many as 50,000 dif-
ferent ones in all (Olivera 1990). One hundred or so of these toxins
have been studied to date and have demonstrated such selectivity for
specific receptors that some have been used, for example, to help char-
acterize subtypes of nicotinic acetylcholine receptors in mammalian
heart muscle, leading to a better understanding of the mechanisms
that control heart rate and contractility (Bibevski et al. 2000). Others
are being developed as medicines, including a painkiller possibly
1,000 times more potent than morphine but that does not cause tol-
erance or addiction (Bowersox et al. 1996). This painkiller may soon
come on the market in Europe for the treatment of severe, chronic
pain, a condition that often defies treatment with opiates such as
morphine because of tolerance. Other cone snail toxins are being
investigated for treating intractable epilepsy (McIntsosh et al. 2001),
for preventing nerve cell death when there is inadequate circulation
(Williams et al. 2002),
and for the early diag-
nosis and treatment of
small cell carcinomas
of the lung, one of the
most aggressive human
cancers (Codignola et al. 1996; Sher et al. 2000). Cone snails may
contain the largest and most clinically important pharmacopoeia of
any genus in nature, and yet, as coral reefs and mangroves are in dan-
ger of being destroyed, so are they (Chivian et al. 2003). 
The importance of biodiversity to human health is particularly
well illustrated by some human infectious diseases. Lyme disease, the
most common vectorborne disease in the United States, is a prime
example. When high levels of vertebrate-species diversity exist in a
Lyme disease area, the risk of getting Lyme disease is lessened. One
reason is that some of the vertebrates that are bitten by infected ticks,
the vectors which transmit the Lyme bacteria, are “dead end”
hosts—poorly able or incapable of passing on the bacteria and con-
tinuing the disease cycle. This effectively “dilutes” the disease agent
and makes it less likely for an infected tick to transmit the disease to
a human (Ostfeld and Keesing 2000a). Another reason this diversity
is beneficial is that some vertebrate species compete with the main
Lyme reservoir host or carrier (the white-footed mouse in the eastern
United States), whereas others are predators—in both cases keeping
mice populations low and reducing disease risk. This buffering effect
conferred by biodiversity may also apply to other human infectious
diseases such as West Nile encephalitis, cutaneous and visceral leish-
maniasis, African trypanosomiasis, and Chagas disease (Ostfeld and
Keesing 2000b).
Finally, and most importantly, ecosystems provide the life support
systems for all life, including human life, on Earth. Not only do they
give us food and fuel, but ecosystems, among other things, purify air
and fresh water, bind and detoxify poisonous substances, break down
wastes and recycle nutrients on land and in the oceans, pollinate crops
and natural vegetation, make soils fertile, and store carbon, mitigating
human-caused climate change (Melillo and Sala 2002). We tend to
take these services for granted and generally do not recognize that we
cannot live without them. Nor do we understand many ecosystem
services well enough to recreate them, not knowing what species are
necessary for the services to work and in what proportions, or whether
for some services there are essential or “keystone” species without
which ecosystems would cease to function. Human activity may now
be altering some ecosystems in destructive ways that we are unaware
of and that could lead to a collapse of their functioning.
The importance of recognizing how biodiversity affects human
health and how it is increasingly threatened by human activity will
only increase in coming years. Physicians and environmental scien-
tists will need to understand these interconnections because they
will be called upon to explain them to policy makers and the public.
Such knowledge will also be critically important in clinical medi-
cine, particularly in relation to the emergence and spread of some
human infectious diseases. Our center and others, such as the
Consortium for Conservation Medicine, are working to better
understand how human health depends on the health of other
species and on the natural functioning of healthy ecosystems, and to
help disseminate this understanding more widely.
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Perspectives EditorialLast month, we announced that EHP would become an open access
journal. That promise is now a reality. The Internet affords us a unique
opportunity to enhance scientific discourse. Therefore, all research arti-
cles are now freely accessible on our website (http://www.ehponline.org/)
immediately upon acceptance following a demanding peer-review
process. Also, all archival research content and current news and
announcements are now freely available. We are finalizing arrangements
to conform to another essential feature of the open access model by
depositing EHP’s research content into a public digital library archive
where the material will be permanently preserved and freely available for
search and retrieval; we have chosen to use PubMed Central.
Be assured that EHP ’s conversion to an open access journal will
not affect the high quality that is expected of articles published in
EHP. We will maintain our rigorous peer-review process, editorial
oversight, and high production standards. Coinciding with the con-
version to open access, We have also expanded and updated our
website, which houses over 10,000 archived research articles. This
expansion makes material more easily accessible for an expected large
increase in the number of visitors.
The struggle for open access to scientific literature has been a
long one and is ongoing. Some of the innovative work on the road
to open access included Paul Ginsparg’s launch in 1991 of arXiv.org
e-Print archive (http://
arxiv.org/), an Internet
server for posting
preprints of high-
energy physics
research articles with
free access to all researchers. Another important step occurred in
1995, when the British Medical Journal became the first medical
journal to provide free access to full text of all its articles (http://
bmj.bmjjournals.com/).
In 1999, Harold Varmus developed plans for a National Library
of Medicine digital archive to improve access to scientific literature,
in the hope that journals would make content available to this digital
archive without restrictions. In 2000, this archive, now known as
PubMed Central (http://www.pubmedcentral.nih.gov/), became a
reality, with some content provided by Proceedings of the National
Academy of Sciences and Molecular Biology of the Cell. However, the
timeliness of the deposition of published articles into PubMed
Central remains an issue. 
The open access philosophy was formalized at a meeting of scien-
tific editors and publishers held in Budapest in December 2001 and
organized by the Open Society Institute, a foundation seeking to fur-
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ther the open access paradigm (http://www.soros.org/initiatives/
information/focus_areas/openaccess). A consensus statement from
that meeting, called the Budapest Open Access Initiative, laid out the
goals and issues involved in providing peer-reviewed scientific litera-
ture on the Internet without restriction. The statement (http://
www.soros.org/openaccess/read.shtml) says in part, 
Removing access barriers to this literature will accelerate research, enrich edu-
cation, share the learning of the rich with the poor and the poor with the rich,
make this literature as useful as it can be, and lay the foundation for uniting
humanity in a common intellectual conversation and quest for knowledge.
The benefits of open access were not lost on the commercial sector,
and in 2000, BioMed Central (BMC) was initiated as a commercial
venture to publish open access research articles in a series of new BMC
journals (http://www.biomedcentral.com/). BMC’s business model
requires author funding, and there is a charge for print subscriptions. 
In 2001, a nonprofit organization was formed to publish
another group of open access journals that would compete with
the highest-ranking journals; these journals would become known
collectively as the Public Library of Science (PLoS; http://www.
publiclibraryofscience.org/). The first issue of the first journal, PLoS
Biology, was published in October 2003. PloS’s business model is
also based on author funding and paid print subscriptions. 
Other journals are considering open access. For example,
Oxford University Press is experimenting with open access for its
journal Nucleic Acid Research (http://www3.oup.co.uk/nar/special/
14/default.html). Oxford University Press will use an author-funded
publishing model for the annual “Database Issue” published in
January 2004. If that first step proves successful, the rest of the jour-
nal would gradually move to an open access model over the next
4–5 years.
Funding is always a question when open access is discussed. The
National Institute of Environmental Health Sciences has decided
that adequate resources will be made available to help offset initial
revenue loss. We anticipate that taxpayer funding will decrease as
we gradually switch to an author-funded business model, and we
will maintain our print subscription service. 
Converting to an open access model is also part of efforts by EHP
to reach out to an international audience. EHP currently provides
complimentary print copies of the journal to institutions in develop-
ing countries, and recently EHP began posting online translations of
article summaries in Chinese, French, Japanese, Russian, and
Spanish (http://ehpnet1.niehs.nih.gov/docs/iti.html). We are com-
mitted to doing everything we can to allow the cutting-edge environ-
mental health research published in our journal to benefit people
across the globe.
After carefully considering various scientific publishing models,
we have concluded that the rationale behind the open access philoso-
phy—that science best benefits society when it is freely and immedi-
ately available to all—is too compelling to ignore. As part of the
U.S. government, we feel it is incumbent on us to take a leadership
role in this area. We invite all EHP readers to take full advantage of
this new accessibility, and we strongly encourage you to share this
resource with your colleagues around the world. The more we know
and the more we share, the more progress we can make toward
environmental health for all.
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